Diligence memo · auto-generated · as of July 2, 2026
Fs Usme Lp
Fs Usme Lp looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Fs Usme Lp operates in Other Health Care, based in LOS ANGELES.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Fs Usme Lp has raised $282M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $282M on 2020-11-24.
Most recent recorded round closed around 2020-11-24.
Valuation (modeled)modeled
Provath models Fs Usme Lp at approximately $6.0B (range $1.5B–$12.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.80× the median modeled value of Series D+ Other Health Care companies in 2019–2021 (26 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 5.6 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: ZAHN Parent, LLC, Covetrus, Inc., EQH Parent, LLC, SonerMed, LLC, Medable Inc..
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.